Table 1
Groups | TP | MPAP (mmHg) | PVR (dyn*s*cm-5) | MAP (mmHg) | SVR (dyn*s*cm-5) | CO (L/min) |
|---|---|---|---|---|---|---|
Controls | T0 | 14 ± 3 | 205 ± 107 | 92 ± 6 | 2157 ± 520 | 3.5 ± 0.9 |
T1 | 33 ± 6 | 360 ± 97 | 74 ± 13 | 966 ± 212 | 6.2 ± 0.7 | |
T2 | 27 ± 5 | 243 ± 78 | 67 ± 10 | 798 ± 196 | 6.6 ± 0.9 | |
NaNO2 i.v. low dose | T0 | 15 ± 1 | 185 ± 26 | 90 ± 13 | 1967 ± 417 | 3.7 ± 0.4 |
T1 | 34 ± 3 | 429 ± 78 | 72 ± 10 | 1092 ± 293 | 5.1 ± 0.5 | |
T2 | 29 ± 6 | 284 ± 82 | 68 ± 11 | 816 ± 320 | 6.9 ± 1.6 | |
Mean pulmonary artery pressure (MPAP), pulmonary vascular resistance (PVR), mean arterial pressure (MAP), systemic vascular resistance (SVR), cardiac output (CO) in control animals (Controls; n = 6) and in animals treated with low dose intravenous sodium nitrite (NaNO2 i.v.; n = 6); Time point of measurement (TP): Baseline (T0); ARDS baseline (T1); End of experiment (T2); All values: mean ± SD | ||||||